Newsletter
Frontline Treatment of DLBCL: Practice Implications
Andrew D. Zelenetz, MD, PhD
|
Newsletter
Treating Relapsed/Refractory DLBCL: Practice Implications
Matthew Lunning, DO, FACP
|
Newsletter
Addressing Disparities in Care for Patients with DLBCL
Loretta J. Nastoupil, MD
|
CE Education
Faculty Roundtable on CAR T-cell Therapies, Bispecific Antibodies and Antibody-Drug Conjugates in Follicular Lymphoma
Loretta J. Nastoupil, MD and Catherine S. Diefenbach, MD
|
CE Education
Improving the Spectrum of Care for Patients with Diffuse Large B-cell Lymphoma
James O. Armitage, MD; John P. Leonard, MD; and Jason Westin, MD, MS, FACP |
CE Education
Spotlight on Relapsed/Refractory Follicular Lymphoma
James O. Armitage, MD; and Reid W. Merryman, MD |
CE Education
New Directions in the Frontline Treatment of DLBCL: Implications for Practice
James O. Armitage, MD; and Andrew D. Zelenetz, MD, PhD |
CE Education
New Directions in the Treatment of Relapsed/Refractory DLBCL: Implications for Practice
James O. Armitage, MD; and Matthew Lunning, DO, FACP |
CE Education
Current and Emerging Directions in the Frontline Treatment of Follicular Lymphoma: Implications for Practice
James O. Armitage, MD; and Gilles Salles, MD, PhD |
CE Education
Addressing Disparities in Care for Patients with DLBCL
James O. Armitage, MD; and Loretta J. Nastoupil, MD |
